Trial Profile
Phase Ib Study of Icosabutate, a Novel Structurally Enhanced Fatty Acid, in Subjects With Hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Apr 2015
Price :
$35
*
At a glance
- Drugs Icosabutate (Primary)
- Indications Hypercholesterolaemia; Hyperlipidaemia
- Focus Pharmacodynamics
- Sponsors Pronova BioPharma
- 28 Apr 2015 New trial record